Gregory P. Hanson, CHIEF FINANCIAL OFFICER, SECR at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), bought 4,286 shares at $1.75 ($8K) on 2017-05-19, disclosed to the SEC on 2017-08-02.
Open-market purchase of $8k MBVX by CHIEF FINANCIAL OFFICER, SECR. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| MBVX | SELL | 2017-04-14 | $8K | — | Filing → |
| MBVX | SELL | 2017-04-11 | $2K | — | Filing → |
| MBVX | SELL | 2017-04-06 | $8K | — | Filing → |